Alzheimer's disease, Lewy body disease and aging: A comparative study of the perforant pathway

C. F. Lippa, D. Pulaski-Salo, Dennis W Dickson, T. W. Smith

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The relationship between Alzheimer's disease (AD) and Lewy body disease (LED) is poorly understood. In AD there is severe loss of neurons comprising the perforant pathway. To assess perforant pathway integrity in pure LED we compared neuronal counts in layer II of the entorhinal cortex (ERC) in 11 cases of pure LED that did not meet CERAD pathologic criteria for AD with ERC neuronal counts from seven AD cases with a similar disease duration and six cognitively normal individuals. We counted cell bodies/island in layer II of the ERC using formalin-fixed, paraffin-embedded, tau/cresyl violet-stained sections at the level of the rostral-most body of the hippocampus. There was marked variability in neuronal counts among cases in the LED group; LED data overlapped with data from both normal and AD groups. Overall, perforant pathway perikaryal counts in LED differed significantly from those in AD, but not from those in aged normals (mean perikarya/island = 30.09 ± 8.95, 7.57 ± 6.08, and 38.83 ± 8.98, respectively; F=26.131, P<0.001). The percent of remaining neurons bearing neurofibrillary tangles in LED also overlapped with AD and control groups (16.17 ± 13.85%, 87.86 ± 11.81%, and 24.36 ± 13.30% of remaining neurons, respectively, F=65.62, P<0.001). We conclude that although perforant pathway neuronal loss may occur in LED, it is more often milder and more variable than that seen in AD.

Original languageEnglish (US)
Pages (from-to)161-166
Number of pages6
JournalJournal of the Neurological Sciences
Volume147
Issue number2
DOIs
StatePublished - Apr 15 1997
Externally publishedYes

Fingerprint

Perforant Pathway
Lewy Body Disease
Alzheimer Disease
Entorhinal Cortex
Neurons
Islands
Neurofibrillary Tangles
Paraffin
Formaldehyde
Hippocampus
Control Groups

Keywords

  • Alzheimer's disease
  • Dementia
  • Lewy body disease
  • Perforant pathway

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Alzheimer's disease, Lewy body disease and aging : A comparative study of the perforant pathway. / Lippa, C. F.; Pulaski-Salo, D.; Dickson, Dennis W; Smith, T. W.

In: Journal of the Neurological Sciences, Vol. 147, No. 2, 15.04.1997, p. 161-166.

Research output: Contribution to journalArticle

@article{b714d153974c493ca17e79ca186f804f,
title = "Alzheimer's disease, Lewy body disease and aging: A comparative study of the perforant pathway",
abstract = "The relationship between Alzheimer's disease (AD) and Lewy body disease (LED) is poorly understood. In AD there is severe loss of neurons comprising the perforant pathway. To assess perforant pathway integrity in pure LED we compared neuronal counts in layer II of the entorhinal cortex (ERC) in 11 cases of pure LED that did not meet CERAD pathologic criteria for AD with ERC neuronal counts from seven AD cases with a similar disease duration and six cognitively normal individuals. We counted cell bodies/island in layer II of the ERC using formalin-fixed, paraffin-embedded, tau/cresyl violet-stained sections at the level of the rostral-most body of the hippocampus. There was marked variability in neuronal counts among cases in the LED group; LED data overlapped with data from both normal and AD groups. Overall, perforant pathway perikaryal counts in LED differed significantly from those in AD, but not from those in aged normals (mean perikarya/island = 30.09 ± 8.95, 7.57 ± 6.08, and 38.83 ± 8.98, respectively; F=26.131, P<0.001). The percent of remaining neurons bearing neurofibrillary tangles in LED also overlapped with AD and control groups (16.17 ± 13.85{\%}, 87.86 ± 11.81{\%}, and 24.36 ± 13.30{\%} of remaining neurons, respectively, F=65.62, P<0.001). We conclude that although perforant pathway neuronal loss may occur in LED, it is more often milder and more variable than that seen in AD.",
keywords = "Alzheimer's disease, Dementia, Lewy body disease, Perforant pathway",
author = "Lippa, {C. F.} and D. Pulaski-Salo and Dickson, {Dennis W} and Smith, {T. W.}",
year = "1997",
month = "4",
day = "15",
doi = "10.1016/S0022-510X(96)05321-X",
language = "English (US)",
volume = "147",
pages = "161--166",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Alzheimer's disease, Lewy body disease and aging

T2 - A comparative study of the perforant pathway

AU - Lippa, C. F.

AU - Pulaski-Salo, D.

AU - Dickson, Dennis W

AU - Smith, T. W.

PY - 1997/4/15

Y1 - 1997/4/15

N2 - The relationship between Alzheimer's disease (AD) and Lewy body disease (LED) is poorly understood. In AD there is severe loss of neurons comprising the perforant pathway. To assess perforant pathway integrity in pure LED we compared neuronal counts in layer II of the entorhinal cortex (ERC) in 11 cases of pure LED that did not meet CERAD pathologic criteria for AD with ERC neuronal counts from seven AD cases with a similar disease duration and six cognitively normal individuals. We counted cell bodies/island in layer II of the ERC using formalin-fixed, paraffin-embedded, tau/cresyl violet-stained sections at the level of the rostral-most body of the hippocampus. There was marked variability in neuronal counts among cases in the LED group; LED data overlapped with data from both normal and AD groups. Overall, perforant pathway perikaryal counts in LED differed significantly from those in AD, but not from those in aged normals (mean perikarya/island = 30.09 ± 8.95, 7.57 ± 6.08, and 38.83 ± 8.98, respectively; F=26.131, P<0.001). The percent of remaining neurons bearing neurofibrillary tangles in LED also overlapped with AD and control groups (16.17 ± 13.85%, 87.86 ± 11.81%, and 24.36 ± 13.30% of remaining neurons, respectively, F=65.62, P<0.001). We conclude that although perforant pathway neuronal loss may occur in LED, it is more often milder and more variable than that seen in AD.

AB - The relationship between Alzheimer's disease (AD) and Lewy body disease (LED) is poorly understood. In AD there is severe loss of neurons comprising the perforant pathway. To assess perforant pathway integrity in pure LED we compared neuronal counts in layer II of the entorhinal cortex (ERC) in 11 cases of pure LED that did not meet CERAD pathologic criteria for AD with ERC neuronal counts from seven AD cases with a similar disease duration and six cognitively normal individuals. We counted cell bodies/island in layer II of the ERC using formalin-fixed, paraffin-embedded, tau/cresyl violet-stained sections at the level of the rostral-most body of the hippocampus. There was marked variability in neuronal counts among cases in the LED group; LED data overlapped with data from both normal and AD groups. Overall, perforant pathway perikaryal counts in LED differed significantly from those in AD, but not from those in aged normals (mean perikarya/island = 30.09 ± 8.95, 7.57 ± 6.08, and 38.83 ± 8.98, respectively; F=26.131, P<0.001). The percent of remaining neurons bearing neurofibrillary tangles in LED also overlapped with AD and control groups (16.17 ± 13.85%, 87.86 ± 11.81%, and 24.36 ± 13.30% of remaining neurons, respectively, F=65.62, P<0.001). We conclude that although perforant pathway neuronal loss may occur in LED, it is more often milder and more variable than that seen in AD.

KW - Alzheimer's disease

KW - Dementia

KW - Lewy body disease

KW - Perforant pathway

UR - http://www.scopus.com/inward/record.url?scp=0031569804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031569804&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(96)05321-X

DO - 10.1016/S0022-510X(96)05321-X

M3 - Article

C2 - 9106122

AN - SCOPUS:0031569804

VL - 147

SP - 161

EP - 166

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -